Shockwave Medical Inc (NASDAQ:SWAV)
| 197.51 Delayed Data As of Jun 24 |  +11.49 / +6.18%Today’s Change | 113.36 Today|||52-Week Range 249.73 | +10.76% Year-to-Date |
Latest SWAV News | Press Releases
Today’s Trading
| Previous close | 186.02 |
| Today’s open | 186.51 |
| Day’s range | 186.51 - 199.71 |
| Volume | 28,308 |
| Average volume (3 months) | 571,310 |
| Market cap | $7.1B |
Data as of 4:01pm ET, 06/24/2022
Growth & Valuation
| Earnings growth (last year) | +86.89% |
| Earnings growth (this year) | +890.38% |
| Earnings growth (next 5 years) | +106.00% |
| Revenue growth (last year) | +249.83% |
| P/E ratio | 243.8 |
| Price/Sales | 26.39 |
| Price/Book | 28.97 |
Competitors
Data as of 4:01pm ET, 06/24/2022
Financials
| Next reporting date | August 9, 2022 |
| EPS forecast (this quarter) | $0.45 |
| Annual revenue (last year) | $237.1M |
| Annual profit (last year) | -$9.1M |
| Net profit margin | -3.85% |
Profile
Sector Health Technology |
Industry Medical Specialties |
No executives to display |
Corporate headquarters Santa Clara, California |
Forecasts
